117 related articles for article (PubMed ID: 4004888)
1. Inhibitory effects of probenecid on the individual transport routes which mediate the influx and efflux of methotrexate in L1210 cells.
Henderson GB; Zevely EM
Biochem Pharmacol; 1985 May; 34(10):1725-9. PubMed ID: 4004888
[TBL] [Abstract][Full Text] [Related]
2. Characterization of the individual transport routes that mediate the influx and efflux of methotrexate in CCRF-CEM human lymphoblastic cells.
Henderson GB; Tsuji JM; Kumar HP
Cancer Res; 1986 Apr; 46(4 Pt 1):1633-8. PubMed ID: 3948152
[TBL] [Abstract][Full Text] [Related]
3. The issues of transport multiplicity and energetics pertaining to methotrexate efflux in L1210 cells addressed by an analysis of cis and trans effects of inhibitors.
Sirotnak FM; O'Leary DF
Cancer Res; 1991 Mar; 51(5):1412-7. PubMed ID: 1997179
[TBL] [Abstract][Full Text] [Related]
4. Identification of cholate as a shared substrate for the unidirectional efflux systems for methotrexate in L1210 mouse cells.
Henderson GB; Tsuji JM
Biochim Biophys Acta; 1990 Jan; 1051(1):60-70. PubMed ID: 2297542
[TBL] [Abstract][Full Text] [Related]
5. Increased accumulation of methotrexate by murine tumor cells in vitro in the presence of probenecid which is mediated by a preferential inhibition of efflux.
Sirotnak FM; Moccio DM; Young CW
Cancer Res; 1981 Mar; 41(3):966-70. PubMed ID: 7459883
[TBL] [Abstract][Full Text] [Related]
6. Transport routes utilized by L1210 cells for the influx and efflux of methotrexate.
Henderson GB; Zevely EM
J Biol Chem; 1984 Feb; 259(3):1526-31. PubMed ID: 6693422
[TBL] [Abstract][Full Text] [Related]
7. Altered expression of unidirectional extrusion routes for methotrexate and cholate in an efflux variant of L1210 cells.
Henderson GB; Hughes TR
Biochim Biophys Acta; 1993 Oct; 1152(1):91-8. PubMed ID: 8399310
[TBL] [Abstract][Full Text] [Related]
8. Methotrexate efflux in L1210 cells. Kinetic and specificity properties of the efflux system sensitive to bromosulfophthalein and its possible identity with a system which mediates the efflux of 3',5'-cyclic AMP.
Henderson GB; Tsuji JM
J Biol Chem; 1987 Oct; 262(28):13571-8. PubMed ID: 2820975
[TBL] [Abstract][Full Text] [Related]
9. Comparison of transport properties of the reduced folate carrier and folate receptor in murine L1210 leukemia cells.
Sierra EE; Brigle KE; Spinella MJ; Goldman ID
Biochem Pharmacol; 1995 Oct; 50(8):1287-94. PubMed ID: 7488246
[TBL] [Abstract][Full Text] [Related]
10. Characterization of the multiple transport routes for methotrexate in L1210 cells using phthalate as a model anion substrate.
Henderson GB; Zevely EM
J Membr Biol; 1985; 85(3):263-8. PubMed ID: 3897547
[TBL] [Abstract][Full Text] [Related]
11. Distinguishing between folate receptor-alpha-mediated transport and reduced folate carrier-mediated transport in L1210 leukemia cells.
Spinella MJ; Brigle KE; Sierra EE; Goldman ID
J Biol Chem; 1995 Apr; 270(14):7842-9. PubMed ID: 7713875
[TBL] [Abstract][Full Text] [Related]
12. Mediation of cellular anion detoxification in leukemic cells by unidirectional efflux pumps.
Henderson GB
Adv Enzyme Regul; 1989; 29():61-72. PubMed ID: 2561249
[TBL] [Abstract][Full Text] [Related]
13. Separation and inhibitor specificity of a second unidirectional efflux route for methotrexate in L1210 cells.
Henderson GB
Biochim Biophys Acta; 1992 Oct; 1110(2):137-43. PubMed ID: 1390842
[TBL] [Abstract][Full Text] [Related]
14. Identification of the bromosulfophthalein-sensitive efflux route for methotrexate as the site of action of vincristine in the vincristine-dependent enhancement of methotrexate uptake in L1210 cells.
Henderson GB; Tsuji JM
Cancer Res; 1988 Nov; 48(21):5995-6001. PubMed ID: 2844396
[TBL] [Abstract][Full Text] [Related]
15. ATP-dependent efflux of 2,4-dinitrophenyl-S-glutathione. Properties of two distinct transport systems in inside-out vesicles from L1210 cells and a variant subline with altered efflux of methotrexate and cholate.
Saxena M; Henderson GB
J Biol Chem; 1995 Mar; 270(10):5312-9. PubMed ID: 7890643
[TBL] [Abstract][Full Text] [Related]
16. Energy-dependent efflux of methotrexate in L1210 leukemia cells. Evidence for the role of an ATPase obtained with inside-out plasma membrane vesicles.
Schlemmer SR; Sirotnak FM
J Biol Chem; 1992 Jul; 267(21):14746-52. PubMed ID: 1386081
[TBL] [Abstract][Full Text] [Related]
17. Effects of metabolic deprivation on methotrexate transport in L1210 leukemia cells: further evidence for separate influx and efflux systems with different energetic requirements.
Dembo M; Sirotnak FM; Moccio DM
J Membr Biol; 1984; 78(1):9-17. PubMed ID: 6708095
[TBL] [Abstract][Full Text] [Related]
18. Transport of methotrexate in L1210 cells. Mechanism for inhibition by p-chloromercuriphenylsulfonate and N-ethylmaleimide.
Henderson GB; Zevely EM
Biochim Biophys Acta; 1981 Jan; 640(2):549-56. PubMed ID: 6260257
[TBL] [Abstract][Full Text] [Related]
19. Carrier-mediated transport of folate compounds in L1210 cells. Initial rate kinetics and extent of duality of entry routes for folic acid and diastereomers of 5-methyltetrahydrohomofolate in the presence of physiological anions.
Sirotnak FM; Goutas LJ; Jacobsen DM; Mines LS; Barrueco JR; Gaumont Y; Kisliuk RL
Biochem Pharmacol; 1987 May; 36(10):1659-67. PubMed ID: 3593392
[TBL] [Abstract][Full Text] [Related]
20. Protein binding as a component of drug interaction in cellular pharmacokinetic studies. Effects of probenecid on transport and accumulation of methotrexate in Ehrlich ascites tumor cells in vitro.
Gewirtz DA; Holt SA
Biochem Pharmacol; 1985 Mar; 34(6):747-54. PubMed ID: 3977951
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
